BVS

Bioventus Inc.

Price

$13.13

return (12m)

87.04%

p/e

15.04

p/bv

3.20

DIVIDEND YIELD

0.00%

BVS price

Bioventus

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment BVS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-6.68%

3 months

12.80%

1 year

87.04%

2 years

11.74%

5 years

-6.75%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals BVS

Valuation

P/E

15.04

Sector 1.08

Industry 3.46

P/BV

3.20

Sector 1.87

Industry 2.13

P/Revenue (PSR)

1.53

Sector 1.53

Industry 1.72

EV/EBITDA

35.88

Sector -46.64

Industry 1.72

EV/EBIT

56.15

Sector -50.35

Industry -4.29

P/EBITDA

8.56

Sector -31.90

Industry -53.68

P/EBIT

15.17

Sector -43.90

Industry -50.97

P/Total Assets

1.32

Sector 0.85

Industry 0.96

P/Net Current Assets

-6.41

Sector -26.05

Industry -11.19

P/Working Capital

8.45

Sector -3.95

Industry 2.92

EPS

0.87

Sector -0.70

Industry -0.60

BVPS

4.09

Sector 4.48

Industry 4.74

Efficiency

Gross Margin

68.65%

Sector 49.44%

Industry 50.68%

EBITDA Margin

19.79%

Sector -282.02%

Industry -57.47%

EBIT Margin

12.65%

Sector -164.03%

Industry -56.25%

Operating Margin

10.02%

Sector -19.60%

Industry -25.80%

Net Profit Margins

10.14%

Sector -23.82%

Industry -29.17%

Asset Turnover

0.23

Sector 0.13

Industry 0.15

Profitability

ROE

21.27%

Sector -23.80%

Industry -22.30%

ROA

8.76%

Sector -24.22%

Industry -24.15%

ROIC

14.24%

Sector -587.47%

Industry -96.49%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

1.69

Sector 1.90

Industry 1.98

Net Debt / EBITDA

6.60

Sector -23.34

Industry -2.21

Net Debt / EBIT

10.33

Sector -11.26

Industry -1.50

Net Debt / Equity

0.72

Sector -0.63

Industry -0.29

Gross Debt / Equity

0.83

Sector -0.73

Industry -0.82

Equity/Assets

0.41

Sector 0.46

Industry 0.47

Liabilities/Assets

0.59

Sector 0.50

Industry 0.52

Growth

5Y Revenue CAGR

6.19%

Sector -

Industry -

5Y Earnings CAGR

24.95%

Sector -

Industry -

Fundamentals BVS

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Bioventus ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$13.13

Fair Value

$8.95

Upside

-31.85%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
BVS Bioventus Inc.	$13.13	87.04%	0.00%	15.04	3.20	21.27%	10.14%
ABT Abbott Laboratories	$97.50	-25.43%	2.53%	31.55	3.35	10.61%	11.65%
MDT Medtronic PLC	$86.38	-7.98%	3.30%	21.10	2.17	10.29%	13.93%
BSX Boston Scientific Corp.	$42.60	-56.23%	0.00%	17.31	2.55	14.73%	17.49%
TMDX TransMedics Group Inc.	$79.80	-31.03%	0.00%	17.68	5.18	29.28%	22.69%
RMD ResMed Inc.	$218.89	-20.60%	1.12%	20.92	4.84	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$518.39	-17.87%	0.00%	36.04	25.47	70.67%	25.03%
COHR Coherent Inc.	$337.04	196.74%	0.00%	81.57	5.84	7.16%	11.31%
SYK Stryker Corp.	$275.43	-24.66%	1.27%	28.21	4.38	15.55%	14.43%
PHG Koninklijke Philips NV	$23.92	-11.21%	4.25%	17.60	1.72	9.80%	6.30%
INMD InMode Ltd.	$14.09	-7.00%	0.00%	10.69	1.32	12.32%	20.69%
BDX Becton Dickinson and Company	$176.80	-6.41%	2.39%	51.40	1.98	3.85%	6.29%
DXCM DexCom Inc.	$85.36	27.31%	0.00%	32.65	12.45	38.14%	20.12%
EW Edwards Lifesciences Corp.	$85.15	10.48%	0.00%	48.96	4.59	9.37%	15.43%
ALGN Align Technology Inc.	$143.74	8.75%	0.00%	25.13	2.46	9.77%	9.99%
SNN Smith & Nephew PLC	$26.43	-24.68%	2.96%	19.66	4.27	21.74%	9.20%
IRMD iRadimed Corporation	$85.40	21.25%	1.49%	47.27	10.71	22.66%	26.70%
ZBH Zimmer Biomet Holdings Inc.	$88.29	-11.23%	1.10%	20.85	1.33	6.39%	9.48%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

BVS - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Bioventus

Bioventus Inc.

Average Investor10 user rating

4.0 (0 people)

United States

11 years

Founded: 2015

2021

Time since IPO - 5 years

700

Employees

Bioventus Inc. (United States) is listed on the Nasdaq and has a market capitalization of $887.73 million, with shareholders equity totaling $277.41 million.

The company employs approximately 700 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Bioventus Inc. reported $581.85 million in revenue, generating net income of $59.01 million.

Key financial metrics include a P/E ratio of 15.04, a price-to-book (P/B) ratio of 3.20, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BVS.

Market cap

$887.73 million

Net worth

$277.41 million

$277,412,000.00

Assets

$673.35 million

$673,346,000.00

Total Shares Outstanding

67.87 million

67,869,000

Average Daily Trading Volume

$644.93 Thousand

$644,926.48

Sector

Health

Industry

Medical Supplies and Equipment

BVS

BVS revenue and profits

Financial Results BVS

DRAG THE FRAME TO SEE MORE DATA

BVS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$86.46 15,99% (12M)

P/E

22.49

3.09%

ROE

6.12%

P/BV

1.38

CI - Cigna

$270.53 --11,05% (12M)

P/E

10.33

2.31%

ROE

16.04%

P/BV

1.66

CNC - Centene

$62.99 62,76% (12M)

P/E

-6.05

0.00%

ROE

-22.53%

P/BV

1.36

HUM - Humana

$388.36 39,16% (12M)

P/E

35.89

0.93%

ROE

6.63%

P/BV

2.38

SNY - Sanofi

$39.92 --18,48% (12M)

P/E

3.72

4.45%

ROE

18.43%

P/BV

0.69

JNJ - Johnson & Johnson

$256.03 38,80% (12M)

P/E

29.27

2.06%

ROE

24.76%

P/BV

7.25

LLY - Eli Lilly

$1,142.85 36,94% (12M)

P/E

38.06

0.59%

ROE

78.84%

P/BV

30.01

HCA - HCA Healthcare

$426.69 --0,19% (12M)

P/E

13.82

0.71%

ROE

-213.15%

P/BV

-29.45